Last 7 days
-2.0%
Last 30 days
-14.1%
Last 90 days
-6.4%
Trailing 12 Months
-8.1%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DD | 34.3B | 13.0B | -5.91% | -9.14% | 5.84 | 2.63 | 3.59% | -9.26% |
ALB | 25.5B | 7.3B | -11.63% | 1.86% | 9.49 | 3.49 | 119.96% | 2074.96% |
FMC | 14.8B | 5.8B | -8.58% | -11.28% | 20.13 | 2.56 | 15.01% | -0.42% |
CE | 11.0B | - | -11.07% | -28.10% | 5.82 | 1.15 | 22.25% | 0.21% |
MID-CAP | ||||||||
EMN | 9.5B | 10.6B | -4.57% | -27.51% | 12.04 | 0.9 | 0.99% | -7.47% |
OLN | 6.9B | 9.4B | -13.84% | -1.19% | 5.17 | 0.73 | 5.23% | 2.33% |
HUN | 4.9B | 8.0B | -7.01% | -33.03% | 10.74 | 0.62 | 4.60% | -55.98% |
CC | 4.3B | 6.8B | -14.13% | -8.14% | 7.4 | 0.63 | 7.08% | -4.93% |
BCPC | 3.9B | 942.4M | -8.55% | -10.54% | 37.42 | 4.18 | 17.94% | 9.64% |
LTHM | 3.7B | 813.2M | -11.23% | -19.45% | 13.6 | 4.57 | 93.43% | 45483.33% |
GCP | 2.4B | 999.6M | 1.27% | 44.25% | 215.39 | 2.37 | 3.34% | -90.08% |
SMALL-CAP | ||||||||
KRO | 1.0B | 1.9B | -21.72% | -45.67% | 9.68 | 0.52 | -0.47% | -7.44% |
GURE | 28.1M | 68.4M | -18.79% | -37.09% | 2.41 | 0.41 | 48.74% | 2401.42% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -3.4% | 6,794 | 7,031 | 6,934 | 6,674 | 6,345 |
Gross Profit | -10.6% | 1,616 | 1,808 | 1,803 | 1,570 | 1,381 |
Operating Expenses | 2.6% | 844 | 823 | 806 | 730 | 705 |
S&GA Expenses | 2.3% | 710 | 694 | 678 | 596 | 592 |
R&D Expenses | 1.7% | 118 | 116 | 111 | 113 | 107 |
EBITDA | -23.9% | 1,195 | 1,570 | 1,512 | 1,339 | - |
EBITDA Margin | -21.2% | 0.18* | 0.22* | 0.22* | 0.20* | - |
Earnings Before Taxes | -33.4% | 741 | 1,112 | 1,044 | 857 | 676 |
EBT Margin | -31.0% | 0.11* | 0.16* | 0.15* | 0.13* | - |
Interest Expenses | -1.2% | 163 | 165 | 169 | 176 | 185 |
Net Income | -36.3% | 578 | 908 | 882 | 747 | 608 |
Net Income Margin | -34.1% | 0.09* | 0.13* | 0.13* | 0.11* | - |
Free Cahsflow | -7.8% | 447 | 485 | 500 | 460 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -1.4% | 7,640 | 7,745 | 7,730 | 7,524 | 7,550 |
Current Assets | -9.3% | 3,214 | 3,543 | 3,606 | 3,393 | 3,345 |
Cash Equivalents | -5.6% | 1,102 | 1,167 | 1,248 | 1,145 | 1,451 |
Inventory | 6.3% | 1,404 | 1,321 | 1,219 | 1,166 | 1,099 |
Net PPE | 3.3% | 3,171 | 3,071 | 3,111 | 3,131 | 3,154 |
Goodwill | 0% | 102 | 102 | 102 | 102 | 102 |
Liabilities | 1.1% | 6,533 | 6,460 | 6,515 | 6,357 | 6,468 |
Current Liabilities | -3.1% | 1,891 | 1,951 | 1,886 | 1,775 | 1,858 |
Long Term Debt | -4.0% | 3,510 | 3,656 | 3,692 | 3,724 | - |
LT Debt, Non Current | 2.3% | 3,590 | 3,510 | 3,656 | 3,692 | 3,724 |
Shareholder's Equity | -13.8% | 1,107 | 1,284 | 1,215 | 1,167 | 1,081 |
Retained Earnings | -5.8% | 2,170 | 2,304 | 2,102 | 1,940 | 1,746 |
Additional Paid-In Capital | 0.1% | 1,016 | 1,015 | 1,005 | 956 | 944 |
Accumulated Depreciation | 1.7% | 6,216 | 6,115 | 6,153 | 6,123 | 6,078 |
Shares Outstanding | -3.0% | 149 | 153 | 156 | 157 | 161 |
Minority Interest | 0% | 1.00 | 1.00 | 1.00 | 1.00 | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -6.7% | 754 | 808 | 818 | 783 | 820 |
Share Based Compensation | -20.6% | 27.00 | 34.00 | 31.00 | 32.00 | 34.00 |
Cashflow From Investing | -239.9% | -284 | 203 | 209 | 187 | 220 |
Cashflow From Financing | 1.6% | -685 | -696 | -762 | -707 | -560 |
Dividend Payments | -2.5% | 154 | 158 | 160 | 163 | 164 |
Buy Backs | 11.5% | 495 | 444 | 432 | 317 | 173 |
86.2%
65.4%
57.3%
Y-axis is the maximum loss one would have experienced if Chemours was unfortunately bought at previous high price.
25.7%
-5.8%
49.7%
FIve years rolling returns for Chemours.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | new | - | 201,773 | 201,773 | 0.01% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -0.02 | 205,471 | 1,052,470 | -% |
2023-03-08 | SHEETS SMITH WEALTH MANAGEMENT | sold off | -100 | -274,000 | - | -% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 46.86 | 514,000 | 1,136,000 | 0.01% |
2023-03-03 | ROBOTTI ROBERT | reduced | -0.8 | 687,086 | 3,644,090 | 0.73% |
2023-03-02 | LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | new | - | 377,239 | 377,239 | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -21.28 | -31,707 | 1,398,290 | -% |
2023-02-24 | NATIXIS | new | - | 2,118,900 | 2,118,900 | 0.01% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | reduced | -6.04 | 110,000 | 763,000 | 0.01% |
2023-02-22 | CVA Family Office, LLC | reduced | -86.67 | -7,469 | 1,531 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | sessa capital (master), l.p. | 0.36% | 547,057 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 12.20% | 18,416,153 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 12.3% | 18,516,903 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 12.3% | 18,516,903 | SC 13G/A | |
Apr 08, 2022 | blackrock inc. | 11.3% | 18,075,740 | SC 13G/A | |
Feb 14, 2022 | sessa capital (master), l.p. | 3.6% | 5,748,120 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 9.98% | 16,258,762 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 8.6% | 14,015,490 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 21.94 -23.82% | 31.44 9.17% | 52.76 83.19% | 71.62 148.68% | 84.17 192.26% |
Current Inflation | 20.93 -27.33% | 29.71 3.16% | 47.69 65.59% | 63.85 121.70% | 74.51 158.72% |
Very High Inflation | 19.61 -31.91% | 27.48 -4.58% | 41.56 44.31% | 54.63 89.69% | 63.14 119.24% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 23, 2023 | 8-K | Current Report | |
Mar 16, 2023 | 8-K | Current Report | |
Mar 15, 2023 | 8-K | Current Report | |
Mar 10, 2023 | 4/A | Insider Trading | |
Mar 10, 2023 | DEFA14A | DEFA14A | |
Mar 10, 2023 | DEF 14A | DEF 14A | |
Mar 10, 2023 | ARS | ARS | |
Mar 10, 2023 | 4/A | Insider Trading | |
Mar 10, 2023 | 4/A | Insider Trading | |
Mar 10, 2023 | 4/A | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-06 | Bellezza Alisha | acquired | 658,266 | 23.7504 | 27,716 | president, thermal spec solns |
2023-03-06 | Bellezza Alisha | sold | -983,086 | 35.47 | -27,716 | president, thermal spec solns |
2023-03-02 | Dignam Denise | sold (taxes) | -20,552 | 36.12 | -569 | president, adv perf materials |
2023-03-02 | Sparks Edwin C | sold (taxes) | -653,014 | 36.12 | -18,079 | president, titan tech chem sol |
2023-03-02 | Scarborough Alvenia | sold (taxes) | -20,227 | 36.12 | -560 | svp corp communications & cbo |
2023-03-02 | Wellman Kristine M | sold (taxes) | -18,674 | 36.12 | -517 | svp, gc & corp. secretary |
2023-03-02 | Wisel Camela | sold (taxes) | -17,590 | 36.12 | -487 | vp, cao & controller |
2023-03-02 | Bellezza Alisha | sold (taxes) | -34,061 | 36.12 | -943 | president, thermal spec solns |
2023-03-01 | Newman Mark | sold (taxes) | -182,840 | 34.84 | -5,248 | president and ceo |
2023-03-01 | Scarborough Alvenia | acquired | - | - | 2,332 | svp corp communications & cbo |
Interim Consolidated Statements of Operations (Unaudited) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Income Statement [Abstract] | ||||
Net sales | $ 1,777 | $ 1,680 | $ 5,456 | $ 4,770 |
Cost of goods sold | 1,345 | 1,253 | 4,042 | 3,782 |
Gross profit | 432 | 427 | 1,414 | 988 |
Selling, general, and administrative expense | 140 | 124 | 535 | 433 |
Research and development expense | 32 | 27 | 88 | 78 |
Restructuring, asset-related, and other charges | (1) | 3 | 10 | 4 |
Total other operating expenses | 171 | 154 | 633 | 515 |
Equity in earnings of affiliates | 16 | 12 | 44 | 32 |
Interest expense, net | (41) | (45) | (123) | (142) |
Gain (loss) on extinguishment of debt | 7 | (20) | 7 | (20) |
Other income, net | 56 | 11 | 101 | 31 |
Income before income taxes | 299 | 231 | 810 | 374 |
Provision for (benefit from) income taxes | 59 | 17 | 135 | (1) |
Net income | 240 | 214 | 675 | 375 |
Net income attributable to Chemours | $ 240 | $ 214 | $ 675 | $ 375 |
Per share data | ||||
Basic earnings per share of common stock | $ 1.54 | $ 1.30 | $ 4.30 | $ 2.26 |
Diluted earnings per share of common stock | $ 1.52 | $ 1.27 | $ 4.21 | $ 2.21 |
Interim Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions | Sep. 30, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 1,167 | $ 1,451 |
Accounts and notes receivable, net | 980 | 720 |
Inventories | 1,321 | 1,099 |
Prepaid expenses and other | 75 | 75 |
Total current assets | 3,543 | 3,345 |
Property, plant, and equipment | 9,186 | 9,232 |
Less: Accumulated depreciation | (6,115) | (6,078) |
Property, plant, and equipment, net | 3,071 | 3,154 |
Operating lease right-of-use assets | 232 | 227 |
Goodwill | 102 | 102 |
Other intangible assets, net | 15 | 6 |
Investments in affiliates | 186 | 169 |
Restricted cash and restricted cash equivalents | 201 | 100 |
Other assets | 395 | 447 |
Total assets | 7,745 | 7,550 |
Current liabilities: | ||
Accounts payable | 1,270 | 1,162 |
Compensation and other employee-related cost | 130 | 173 |
Short-term and current maturities of long-term debt | 24 | 25 |
Current environmental remediation | 210 | 173 |
Other accrued liabilities | 317 | 325 |
Total current liabilities | 1,951 | 1,858 |
Long-term debt, net | 3,510 | 3,724 |
Operating lease liabilities | 192 | 179 |
Long-term environmental remediation | 482 | 389 |
Deferred income taxes | 53 | 49 |
Other liabilities | 272 | 269 |
Total liabilities | 6,460 | 6,468 |
Commitments and contingent liabilities (Note 16) | ||
Equity | ||
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 195,178,578 shares issued and 153,078,931 shares outstanding at September 30, 2022; 191,860,159 shares issued and 161,046,732 shares outstanding at December 31, 2021) | 2 | 2 |
Treasury stock, at cost (42,099,647 shares at September 30, 2022; 30,813,427 shares at December 31, 2021) | (1,604) | (1,247) |
Additional paid-in capital | 1,015 | 944 |
Retained earnings | 2,304 | 1,746 |
Accumulated other comprehensive loss | (433) | (364) |
Total Chemours stockholders’ equity | 1,284 | 1,081 |
Non-controlling interests | 1 | 1 |
Total equity | 1,285 | 1,082 |
Total liabilities and equity | $ 7,745 | $ 7,550 |